Clinical Trial Update: A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 study of RO4602522 in patients with Alzheimer's disease and in healthy volunteers, noting its completed status. Sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• RO4602522

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Healthy Volunteer, Alzheimer's Disease | Phase 1 | Status: COMPLETED